N/A
N=297
Blood Glucose Testing and You
Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT01453413 ↗Enrolled (actual)
297
Serious AEs
0.0%
Results posted
Dec 2012
Primary outcome: Primary: Percent of Subjects Outside Specified Blood Glucose (BG) Range -Estimated Versus Measured Blood Glucose — 45.80 percentage of subjects
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Blood Glucose meter (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Ascensia Diabetes Care
- Primary completion
- Nov 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent of Subjects Outside Specified Blood Glucose (BG) Range -Estimated Versus Measured Blood Glucose |
45.80 | — |
| SECONDARY Percent of Subjects Outside a Second Specified Blood Glucose (BG) Range -Estimated Versus Measured Blood Glucose |
57.69 | — |
Summary
The purpose of this study is to determine the difference between self-reported, estimated blood glucose level versus blood glucose levels measured with a Blood Glucose Meter.
Eligibility Criteria
Inclusion Criteria
- Males and females, 18 years of age and above
- Type 2 diabetes
- Able to speak, read, and understand English
- Willing to complete all study procedures
Exclusion Criteria
- Type 1 diabetes
- Currently a user of continuous glucose monitoring system
- Currently pregnant
- Hemophilia or any other bleeding disorder
- Employee of competitive medical device company
- Cognitive disorder or other condition which, in the opinion of the investigator (or designee), would put the person at risk or seriously compromise the integrity of the study
Data sourced from ClinicalTrials.gov (NCT01453413). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.